Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Nature Reviews. Drug Discovery
|
July 4, 2006
B cells move to centre stage: novel opportunities for autoimmune disease treatment
Jeffrey L Browning
Immunological Reviews
|
July 11, 2008
Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
Jeffrey L Browning
Nature Reviews. Immunology
|
July 3, 2002
BAFF: a fundamental survival factor for B cells
Fabienne Mackay, Jeffrey L Browning
Frontiers in Immunology
|
February 28, 2014
Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues
Theresa T Lu, Jeffrey L Browning
Journal of Immunology (Baltimore, Md. : 1950)
|
May 8, 2002
Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos
Jeffrey L Browning, Lars E French
Nature Reviews. Immunology
|
September 17, 2003
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease
Jennifer L Gommerman, Jeffrey L Browning
Cytokine & Growth Factor Reviews
|
April 5, 2014
The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity
Jennifer L Gommerman, Jeffrey L Browning, Carl F Ware
The Journal of Clinical Investigation
|
November 6, 2002
Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway
Jennifer L Gommerman, Fabienne Mackay, Elina Donskoy, et al.
The Journal of Biological Chemistry
|
February 27, 2010
TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor
Pradeep Bista, Weike Zeng, Sarah Ryan, et al.
Neurological Research
|
September 3, 2010
Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury
Marsha A Widmayer, Jeffrey L Browning, Shankar P Gopinath, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Nature Reviews. Drug Discovery
|
July 4, 2006
B cells move to centre stage: novel opportunities for autoimmune disease treatment
Jeffrey L Browning
Immunological Reviews
|
July 11, 2008
Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
Jeffrey L Browning
Nature Reviews. Immunology
|
July 3, 2002
BAFF: a fundamental survival factor for B cells
Fabienne Mackay, Jeffrey L Browning
Frontiers in Immunology
|
February 28, 2014
Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues
Theresa T Lu, Jeffrey L Browning
Journal of Immunology (Baltimore, Md. : 1950)
|
May 8, 2002
Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos
Jeffrey L Browning, Lars E French
Nature Reviews. Immunology
|
September 17, 2003
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease
Jennifer L Gommerman, Jeffrey L Browning
Cytokine & Growth Factor Reviews
|
April 5, 2014
The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity
Jennifer L Gommerman, Jeffrey L Browning, Carl F Ware
The Journal of Clinical Investigation
|
November 6, 2002
Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway
Jennifer L Gommerman, Fabienne Mackay, Elina Donskoy, et al.
The Journal of Biological Chemistry
|
February 27, 2010
TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor
Pradeep Bista, Weike Zeng, Sarah Ryan, et al.
Neurological Research
|
September 3, 2010
Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury
Marsha A Widmayer, Jeffrey L Browning, Shankar P Gopinath, et al.
Page
of 5